These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32634628)

  • 1. Hit-to-lead optimization of a latency-associated nuclear antigen inhibitor against Kaposi's sarcoma-associated herpesvirus infections.
    Kirsch P; Stein SC; Berwanger A; Rinkes J; Jakob V; Schulz TF; Empting M
    Eur J Med Chem; 2020 Sep; 202():112525. PubMed ID: 32634628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Novel Latency-Associated Nuclear Antigen Inhibitors as Antiviral Agents Against Kaposi's Sarcoma-Associated Herpesvirus.
    Kirsch P; Jakob V; Elgaher WAM; Walt C; Oberhausen K; Schulz TF; Empting M
    ACS Chem Biol; 2020 Feb; 15(2):388-395. PubMed ID: 31944659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay Development and High-Throughput Screening for Inhibitors of Kaposi's Sarcoma-Associated Herpesvirus N-Terminal Latency-Associated Nuclear Antigen Binding to Nucleosomes.
    Beauchemin C; Moerke NJ; Faloon P; Kaye KM
    J Biomol Screen; 2014 Jul; 19(6):947-58. PubMed ID: 24518064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragment-Based Discovery of a Qualified Hit Targeting the Latency-Associated Nuclear Antigen of the Oncogenic Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8.
    Kirsch P; Jakob V; Oberhausen K; Stein SC; Cucarro I; Schulz TF; Empting M
    J Med Chem; 2019 Apr; 62(8):3924-3939. PubMed ID: 30888817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Kaposi's sarcoma-associated herpesvirus LANA regions important for episome segregation, replication, and persistence.
    Vázquez Ede L; Carey VJ; Kaye KM
    J Virol; 2013 Nov; 87(22):12270-83. PubMed ID: 24006437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
    Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis.
    Sun Z; Jha HC; Robertson ES
    J Virol; 2015 Oct; 89(20):10206-18. PubMed ID: 26223641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen: Replicating and Shielding Viral DNA during Viral Persistence.
    Weidner-Glunde M; Mariggiò G; Schulz TF
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.
    Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genipin Enhances Kaposi's Sarcoma-Associated Herpesvirus Genome Maintenance.
    Cho M; Jung SW; Lee S; Son K; Park GH; Jung JW; Shin YS; Seo T; Hyosun Cho ; Kang H
    PLoS One; 2016; 11(10):e0163693. PubMed ID: 27736870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells.
    Hu J; Garber AC; Renne R
    J Virol; 2002 Nov; 76(22):11677-87. PubMed ID: 12388727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H2AX phosphorylation is important for LANA-mediated Kaposi's sarcoma-associated herpesvirus episome persistence.
    Jha HC; Upadhyay SK; A J Prasad M; Lu J; Cai Q; Saha A; Robertson ES
    J Virol; 2013 May; 87(9):5255-69. PubMed ID: 23449797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KSHV-specific antivirals targeting the protein-DNA interaction of the latency-associated nuclear antigen.
    Berwanger A; Empting M
    Future Med Chem; 2021 Jul; 13(13):1141-1151. PubMed ID: 34036806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NDRG1 facilitates the replication and persistence of Kaposi's sarcoma-associated herpesvirus by interacting with the DNA polymerase clamp PCNA.
    Zhang F; Liang D; Lin X; Zou Z; Sun R; Wang X; Liang X; Kaye KM; Lan K
    PLoS Pathog; 2019 Feb; 15(2):e1007628. PubMed ID: 30811506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores.
    Xiao B; Verma SC; Cai Q; Kaul R; Lu J; Saha A; Robertson ES
    J Virol; 2010 Oct; 84(19):9718-32. PubMed ID: 20660191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disrupting Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Latent Replication with a Small Molecule Inhibitor.
    Berwanger A; Stein SC; Kany AM; Gartner M; Loretz B; Lehr CM; Hirsch AKH; Schulz TF; Empting M
    J Med Chem; 2023 Aug; 66(15):10782-10790. PubMed ID: 37506283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats.
    Verma SC; Choudhuri T; Kaul R; Robertson ES
    J Virol; 2006 Mar; 80(5):2243-56. PubMed ID: 16474132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
    Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
    mBio; 2018 May; 9(3):. PubMed ID: 29739902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance.
    Skalsky RL; Hu J; Renne R
    J Virol; 2007 Sep; 81(18):9825-37. PubMed ID: 17626102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.